Explore / Peer-reviewed article
Peer-reviewed article

The intensity of the psychedelic experience is reliably associated with clinical improvements: A systematic review and meta-analysis.

Romeo BiD, Kervadec EiD, Fauvel BiD, Strika-Bruneau L, Amirouche A, Bezo A, Piolino P, Benyamina A

Neuroscience and biobehavioral reviewsMar 1, 2025France24 citationsDOI: 10.1016/j.neubiorev.2025.106086

Abstract

<h4>Background</h4>Psychedelic-assisted therapies have demonstrated promising results in treating mental disorders, with results suggesting that the subjective intensity and quality of psychedelic experiences plays a significant role in mediating therapeutic effects. However, the strength of this association across diagnoses and treatment settings remains underexplored.<h4>Methods</h4>We searched MEDLINE, Embase, and PsycINFO databases for studies examining the correlation between the intensity of the psychedelic experience and clinical outcomes in patients treated with classical psychedelics. Meta-correlations were performed, and standardized mean differences of psychedelic experience intensity scores were compared between clinical responders and non-responders using random-effects models. Subgroup analyses were conducted based on diagnosis, study design, setting (clinical vs. naturalistic), and substance used.<h4>Results</h4>A significant positive correlation was found between the intensity of mystical experiences and clinical improvement across all studies (r = .33, p < .0001). Subgroup analyses revealed a stronger association (p = .02) for mood disorders (r = .41) compared to addictions (r = .19). The effect was greater (p < .01) in protocol-based clinical settings (r = .50) than in naturalistic use (r = .14). Prospective designs showed stronger (p < .01) correlations (r = .43) compared to retrospective designs (r = .14).<h4>Conclusion</h4>The intensity of psychedelic experiences is significantly and reliably associated with therapeutic outcomes, particularly in mood disorders. Clinical settings and prospective study designs strengthen this relationship, emphasizing the importance of controlled environments and therapeutic support to fully benefit from the therapeutic potential of psychedelics.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinLSDAddiction

Keywords

Meta-analysisMood DisordersPsychedelicsIntensity Of Psychedelic Experience

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.